该产品被引用文献
1. Fink, G., Pfaff, D. & Levine, J. Handbook of Neuroendocrinology. Handbook of Neuroendocrinology (Elsevier Inc., 2012). doi:10.1016/C2009-0-04284-6 2. Klein, D. C. Arylalkylamine N-acetyltransferase: ‘The timezyme’. Journal of Biological Chemistry 282, 4233–4237 (2007). 3. Voultsios, A., Kennaway, D. J. & Dawson, D. Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin. J. Biol. Rhythms 12, 457–466 (1997). 4. Benloucif, S. et al. Measuring melatonin in humans. J. Clin. sleep Med. JCSM Off. Publ. 4, 66–69 (2008). 5. Jockovich, M., Cosentino, D., Cosentino, L., Wears, R. L. & Seaberg, D. C. Effect of exogenous melatonin on mood and sleep efficiency in emergency medicine residents working night shifts. Acad. Emerg. Med. 7, 955–958 (2000). 6. Almeida Montes, L. G., Ontiveros Uribe, M. P., Cortés Sotres, J. & Heinze Martin, G. Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study. J. Psychiatry Neurosci. 28, 191–6 (2003). 7. Rose, D. A. & Kahan, T. L. Melatonin and sleep qualities in healthy adults: pharmacological and expectancy effects. J. Gen. Psychol. 128, 401–21 (2001). 8. Arendt, J. et al. Some effects of jet-lag and their alleviation by melatonin. Ergonomics 30, 1379–1393 (1987). 9. Beck‐Friis, J. et al. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psychiatr. Scand. 71, 319–330 (1985). 10. Miller, E., Walczak, A., Majsterek, I. & Kedziora, J. Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course. J. Neuroimmunol. 257, 97–101 (2013). 11. Tamura, H. et al. Melatonin and pregnancy in the human. Reproductive Toxicology 25, 291–303 (2008). 12. Sack, R. L., Lewy, A. J., Blood, M. L. & Nakagawa, H. Circadian rhythm abnormalities in totally blind people: Incidence and clinical significance. J. Clin. Endocrinol. Metab. 75, 127–134 (1992).